Analgesics - Eastern Africa | Statista Market Forecast

In Eastern Africa, the revenue in the Analgesics market reaches US$323.14m in 2025.
It is projected to experience an annual growth rate of 9.20% (CAGR 2025-2029).
When compared to other countries worldwide, the United States leads in terms of revenue, generating US$7.60bn in 2025.
Considering the population size, the per person revenue amounts to US$0.69 in 2025.
Eastern Africa's analgesics market is witnessing a surge in demand due to an increased prevalence of chronic pain among the population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

Analgesics: market data & analysis

The Analgesics market in Eastern Africa is experiencing significant growth and development due to various factors. Customer preferences in the Analgesics market in Eastern Africa are influenced by several factors. One of the key preferences is the demand for affordable and accessible pain relief medication. Customers in this region often prioritize cost-effective options that are readily available. Additionally, there is a growing preference for natural and herbal remedies, which has led to the emergence of alternative pain relief products in the market. Several trends are shaping the Analgesics market in Eastern Africa. One notable trend is the increasing urbanization and population growth in the region. As more people move to urban areas, there is a higher demand for analgesics to address the health issues associated with urban living, such as stress, sedentary lifestyles, and pollution. This trend is driving the growth of the market as more individuals seek pain relief solutions. Another trend in the Analgesics market in Eastern Africa is the rise in chronic diseases and conditions. With the aging population and changing lifestyles, there is a higher prevalence of chronic pain conditions such as arthritis and back pain. This has led to an increased demand for analgesics to manage and alleviate these conditions. Local special circumstances also play a role in the development of the Analgesics market in Eastern Africa. Limited access to healthcare facilities and professionals in rural areas has led to a higher reliance on over-the-counter analgesics for pain relief. Additionally, cultural beliefs and practices may influence the choice of pain relief remedies, with some communities preferring traditional or herbal remedies over conventional analgesics. Underlying macroeconomic factors also contribute to the growth of the Analgesics market in Eastern Africa. Economic growth and increasing disposable incomes have allowed more individuals to afford analgesics and prioritize their health and well-being. Additionally, improvements in healthcare infrastructure and the availability of a wider range of analgesic products have made pain relief more accessible to the population. In conclusion, the Analgesics market in Eastern Africa is experiencing growth and development driven by customer preferences for affordable and accessible pain relief medication, as well as the trends of urbanization and the rise in chronic diseases. Local special circumstances and underlying macroeconomic factors also play a role in shaping the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.

Analgesics - Eastern Africa

Revenue

Analyst Opinion

Key Players

Sales Channels

Global Comparison

Methodology

Health

Access more Market Insights on Health topics with our featured report

Key Market Indicators

Explore more high-quality data on related topic

Global pharmaceutical industry - statistics & facts

Contact